Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04317794

Observational, Postmarketing Surveillance Study of Spinraza Injection (Nusinersen Sodium)

Sponsor: Biogen

View on ClinicalTrials.gov

Summary

The primary objective is to evaluate the safety of nusinersen sodium injection in the postmarketing setting in Korea. The secondary objective is to evaluate the effectiveness of nusinersen sodium injection in the postmarketing setting in Korea.

Official title: A Multicenter, Observational, Postmarketing Surveillance Study of Spinraza Injection (Nusinersen Sodium) When Used in Routine Medical Practice in Korea

Key Details

Gender

All

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

74

Start Date

2019-07-02

Completion Date

2027-02-05

Last Updated

2025-07-17

Healthy Volunteers

No

Interventions

DRUG

Nusinersen Sodium Injection

Administered as specified in the treatment arm.

Locations (16)

Pusan Natioanl University Hospital

Busan, South Korea

Samsung Changwon Hospital

Changwon, South Korea

Chungbuk National University Hospital

Cheongju-si, South Korea

Kyungpook National University Hospital

Daegu, South Korea

Yeungnam University Hospital

Daegu, South Korea

Chungnam National University Hospital

Daejeon, South Korea

Chonnam National University Hospital

Gwangju, South Korea

Chonbuk National University Hospital

Jeonju, South Korea

Severance Hospital

Seoul, South Korea

Asan Medical Center

Seoul, South Korea

Korea university Anam Hospital

Seoul, South Korea

Korea University Guro Hospital

Seoul, South Korea

Samsung Medical Center

Seoul, South Korea

Seoul Natioanl University Hospital

Seoul, South Korea

Severance Hospital, Yonsei University Health System

Seoul, South Korea

Pusan National University Yangsan Hospital

Yangsan, South Korea